Try our Advanced Search for more refined results
United Food and Commercial v. Pfizer, Inc.
Case Number:
17-1333
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
December 07, 2017
4th Circ. Frees Pfizer From Antitrust Suit Over Celebrex Patent
The Fourth Circuit on Thursday granted an unopposed motion to dismiss an antitrust suit brought against Pfizer Inc. by a putative class of health benefits plans that alleged the company used anti-competitive practices to get a patent for the inflammation medication Celebrex.
-
October 04, 2017
End Payors Urge 4th Circ. To Revive Celebrex Antitrust Suit
A potential class of health benefit plans told the Fourth Circuit on Tuesday that they're allowed to sue Pfizer Inc. over the tactics it allegedly used to get a patent for the inflammation medication Celebrex, as even though they're indirect purchasers, their states have an exception allowing them to bring antitrust suits.